Log in to your Inderes Free account to see all free content on this page.
Simris Group
0.112
SEK
-3.46 %
Less than 1K followers
SIMRIS B
First North Stockholm
Food & Beverage
Consumer Goods & Services
Overview
Ownership
Investor consensus
-3.46%
+23.89%
+46.33%
+46.33%
+1.36%
-21.48%
-73.96%
-79.69%
-98%
Simris Group is a biotechnology company. The company is focused on research and development as well as the production of bioactive substances from cultured microalgae, for applications in nutrition, cosmeceuticals, and pharmaceuticals. The company's technology also replaces unsustainable raw materials from endangered species and sensitive marine ecosystems. The first product is omega-3 supplements that are sold under their own brand. Simris Group was founded in 2011 and is headquartered in Hammenhög.
Read moreMarket cap
56.28M SEK
Turnover
1.41K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
14.5.
2025
General meeting '25
14.5.
2025
Interim report Q1'25
13.8.
2025
Interim report Q2'25
All
Press releases
3rd party
ShowingAll content types
SIMRIS GROUP YEAR-END REPORT JANUARY-DECEMBER 2024
Bulletin from Simris Group AB’s Extraordinary General Meeting
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio